Literature DB >> 19318594

Donepezil improves cognitive function in mice by increasing the production of insulin-like growth factor-I in the hippocampus.

Noriko Narimatsu1, Naoaki Harada, Hiroki Kurihara, Naomi Nakagata, Kazuya Sobue, Kenji Okajima.   

Abstract

Insulin-like growth factor-I (IGF-I) exerts beneficial effects on cognitive function. The selective acetylcholinesterase inhibitor donepezil increases serum IGF-I levels in elderly subjects. Because stimulation of sensory neurons induces IGF-I production by releasing calcitonin gene-related peptide (CGRP) in the mouse brain, we hypothesized that donepezil increases IGF-I production by sensory neuron stimulation to improve the cognitive function in mice. Donepezil, but not tacrine, increased the CGRP release from dorsal root ganglion neurons isolated from wild-type (WT) mice. Pretreatment with the protein kinase A inhibitor KT5720 [(9S,10S,12R)-2,3,9,10,12-hexahydro-10-hydroxy-9-methyl-1-oxo-9,12-epoxy-1H-diindolo[1,2,3-fg: 3',2',1'-kl]pyrrolo[3,4-i][1,6]-benzo-diazocine-10-carboxylic acid hexyl ester] reversed the effects induced by donepezil. Increase in tissue levels of CGRP, IGF-I, and IGF-I mRNA in the hippocampus was observed at 4 weeks after oral administration of donepezil in WT mice. In these animals, c-fos expression in spinal dorsal horns, parabrachial nuclei, the solitary tract nucleus, and the hippocampus was increased. Enhancement in angiogenesis and neurogenesis was observed in the dentate gyrus of the hippocampus of WT mice after donepezil administration. Improvement of spatial learning was observed in WT mice after donepezil administration. Oral administration of tacrine for 4 weeks produced none of the aforementioned effects induced by donepezil in WT mice. However, none of the effects observed in WT mice was seen after donepezil administration in CGRP-knockout mice and WT mice subjected to functional denervation. These observations suggest that donepezil may improve cognitive function in mice by increasing the hippocampal production of IGF-I through sensory neuron stimulation. These effects of donepezil may not be dependent on its acetylcholinesterase inhibitory activity.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19318594     DOI: 10.1124/jpet.108.147280

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  18 in total

1.  Impaired orthotopic glioma growth and vascularization in transgenic mouse models of Alzheimer's disease.

Authors:  Daniel Paris; Nowel Ganey; Magdalena Banasiak; Vincent Laporte; Nikunj Patel; Myles Mullan; Susan F Murphy; Gi-Taek Yee; Corbin Bachmeier; Christopher Ganey; David Beaulieu-Abdelahad; Venkatarajan S Mathura; Steven Brem; Michael Mullan
Journal:  J Neurosci       Date:  2010-08-25       Impact factor: 6.167

Review 2.  Neuroglialpharmacology: myelination as a shared mechanism of action of psychotropic treatments.

Authors:  George Bartzokis
Journal:  Neuropharmacology       Date:  2012-01-28       Impact factor: 5.250

Review 3.  Estrogen and the prefrontal cortex: towards a new understanding of estrogen's effects on executive functions in the menopause transition.

Authors:  Sheila Shanmugan; C Neill Epperson
Journal:  Hum Brain Mapp       Date:  2012-12-14       Impact factor: 5.038

4.  Age-Related Decline in Brain and Hepatic Clearance of Amyloid-Beta is Rectified by the Cholinesterase Inhibitors Donepezil and Rivastigmine in Rats.

Authors:  Loqman A Mohamed; Hisham Qosa; Amal Kaddoumi
Journal:  ACS Chem Neurosci       Date:  2015-03-30       Impact factor: 4.418

5.  Galantamine and Environmental Enrichment Enhance Cognitive Recovery after Experimental Traumatic Brain Injury But Do Not Confer Additional Benefits When Combined.

Authors:  Patricia B de la Tremblaye; Corina O Bondi; Naima Lajud; Jeffrey P Cheng; Hannah L Radabaugh; Anthony E Kline
Journal:  J Neurotrauma       Date:  2016-12-20       Impact factor: 5.269

6.  Cilostazol prevents amyloid β peptide(25-35)-induced memory impairment and oxidative stress in mice.

Authors:  Masayuki Hiramatsu; Osanao Takiguchi; Aki Nishiyama; Hiromasa Mori
Journal:  Br J Pharmacol       Date:  2010-12       Impact factor: 8.739

Review 7.  Calcitonin gene-related peptide (CGRP): A novel target for Alzheimer's disease.

Authors:  Yogendra Singh; Gaurav Gupta; Birendra Shrivastava; Rajiv Dahiya; Juhi Tiwari; Madhu Ashwathanarayana; Rakesh Kumar Sharma; Mohit Agrawal; Anurag Mishra; Kamal Dua
Journal:  CNS Neurosci Ther       Date:  2017-04-17       Impact factor: 5.243

8.  Donepezil delays photoreceptor apoptosis induced by N-methyl-N-nitrosourea in mice.

Authors:  Longyan Wu; Man Xu; Shengtao Liu; Guo Chen; Fengjun Zhang; Yao Zhao; Jinglin Yi
Journal:  Exp Ther Med       Date:  2016-04-11       Impact factor: 2.447

9.  Insulin-like growth factor-1 and risk of Alzheimer dementia and brain atrophy.

Authors:  Andrew J Westwood; Alexa Beiser; Charles Decarli; Tamara B Harris; Tai C Chen; Xue-Mei He; Ronenn Roubenoff; Aleksandra Pikula; Rhoda Au; Lewis E Braverman; Philip A Wolf; Ramachandran S Vasan; Sudha Seshadri
Journal:  Neurology       Date:  2014-04-04       Impact factor: 9.910

10.  Arterial baroreflex dysfunction impairs ischemia-induced angiogenesis.

Authors:  Changning Hao; Zhen-Hao Huang; Shu-Wei Song; Yi-Qin Shi; Xian Wu Cheng; Toyoaki Murohara; Wei Lu; Ding-Feng Su; Jun-Li Duan
Journal:  J Am Heart Assoc       Date:  2014-05-12       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.